Loading insider details...
Beta
Latest Form 4 (Sep 2, 2026): Grant/Award of 21,750 ELTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 2, 2026 | Elicio Therapeutics, Inc. (ELTX) | Grant/Award | 21,750 | n/a |
| May 20, 2025 | Elicio Therapeutics, Inc. (ELTX) | Grant/Award | 7,900 | n/a |
| Nov 25, 2024 | Elicio Therapeutics, Inc. (ELTX) | Grant/Award | 4,100 | n/a |
| Feb 7, 2024 | Aptose Biosciences Inc. (APTO) | Grant/Award | 3,333 | n/a |
| Dec 29, 2023 | Elicio Therapeutics, Inc. (ELTX) | Grant/Award | 4,100 | n/a |
| Jan 24, 2023 | Aptose Biosciences Inc. (APTO) | Grant/Award | 100,000 | n/a |
| Jan 20, 2022 | Aptose Biosciences Inc. (APTO) | Grant/Award | 50,000 | n/a |
| Jan 6, 2021 | Aptose Biosciences Inc. (APTO) | Grant/Award | 50,000 | n/a |
| Mar 14, 2020 | Aptose Biosciences Inc. (APTO) | Grant/Award | 50,000 | n/a |
| Feb 4, 2020 | Aptose Biosciences Inc. (APTO) | Grant/Award | 65,000 | n/a |